With $160 million in new funding, Freenome looks commercialize its blood test to detect colorectal cancer

16:02 24.07.2019
One of the major problems that technology companies working to find a cure for cancer need to solve is finding a safe, minimally invasive way to detect cancers early. Almost all cancer screening will eventually require a biopsy, but determining whether that’s necessary in the early stages of cancer can mean the difference between life […]...
  179